XML 39 R28.htm IDEA: XBRL DOCUMENT v3.24.2.u1
STOCK-BASED COMPENSATION (Tables)
 3 Months Ended
Jun. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Performance Shares Vesting Based on EPS Targets
The Performance Share performance targets are set forth below.
Trailing 4-Quarter EPS Targets for
September 30, 2018 through March 31, 2025		Restricted Stock Eligible for Vesting
(Percentage of Award)
$16.3540%
$20.4560%
The Performance Option performance target is set forth below.
Trailing 4-Quarter EPS Targets for
September 30, 2018 through March 31, 2025		Options Eligible for Vesting
(Percentage of Award)
$25.30100%
Schedule of Stock Option Activity
Option activity for the three months ended June 30, 2024 was as follows:
 SharesWeighted Average Exercise
Price		Weighted Average
Remaining
Contractual Term		Aggregate Intrinsic Value
Options outstanding, beginning of period267,947 $105.77   
Exercised during period(7,011)97.90   
Forfeited during period(6,699)102.13   
Expired during period(1,431)207.51   
Options outstanding, end of period252,806  2$105.51 4.8 years$5,573,455 
Options exercisable, end of period112,037 $107.69 4.7 years$2,466,448 
Schedule of Intrinsic Value of Options Exercised The total intrinsic value and tax benefit of options exercised during the three months ended June 30, 2024 and 2023 was as follows:
June 30,
2024		June 30,
2023
Intrinsic value of options exercised
$256,797 $215,135 
Tax benefit of options exercised
62,915 52,708 
Summary of the Status and Changes Restricted Stock
A summary of the status of the Company’s restricted stock as of June 30, 2024, and changes during the three months ended June 30, 2024, are presented below:
 SharesWeighted Average Fair Value at Grant Date
Outstanding at March 31, 2024388,577 $101.18 
Vested during the period(3,000)100.79 
Forfeited during the period(18,000)100.79 
Outstanding at June 30, 2024367,577 $101.20 
Schedule of Share-Based Compensation Included as a Component of Net Income (Loss)
Total stock-based compensation included as a component of personnel expenses in the Company's Consolidated Statements of Operations during the three month periods ended June 30, 2024 and 2023 was as follows:
Three months ended June 30,
20242023
Stock-based compensation related to equity classified awards:
Stock-based compensation related to stock options
$143,720 $313,347 
Stock-based compensation (reversal) related to restricted stock3
(1,207,565)1,099,351 
Total stock-based compensation (reversal) related to equity classified awards$(1,063,845)$1,412,698